Rudy Li
Stock Analyst at Wolfe Research
(4.89)
# 352
Out of 5,184 analysts
83
Total ratings
49.3%
Success rate
57.8%
Average return
Main Sectors:
Stocks Rated by Rudy Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRUG Bright Minds Biosciences | Initiated Coverage: Buy | $80 → $150 | $20.40 | +635.29% | 3 | Oct 15, 2026 | |
| OVID Ovid Therapeutics | Initiated Coverage: Buy | $5 | $2.20 | +127.27% | 1 | Oct 15, 2026 | |
| RAPP Rapport Therapeutics | Initiated Coverage: Buy | $50 | $23.16 | +115.89% | 1 | Oct 15, 2026 | |
| HRMY Harmony Biosciences Holdings | Initiated Coverage: Buy | $60 | $32.59 | +84.11% | 1 | Aug 26, 2026 | |
| IMUX Immunic | Reiterated: Buy | $30 → $25 | $6.99 | +257.65% | 3 | Aug 11, 2026 | |
| STOK Stoke Therapeutics | Reiterated: Buy | $40 | $26.81 | +49.20% | 20 | Aug 3, 2026 | |
| QURE uniQure | Upgraded: Buy | $65 | $19.35 | +235.92% | 2 | Jul 29, 2026 | |
| CMPS COMPASS Pathways | Reiterated: Buy | $18 | $8.05 | +123.60% | 1 | Jul 7, 2026 | |
| LBRX LB Pharmaceuticals | Initiated Coverage: Buy | $45 | $38.85 | +15.83% | 1 | Jul 7, 2026 | |
| SPTX Seaport Therapeutics | Initiated Coverage: Hold | n/a | $18.05 | - | 1 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $17.11 | +92.87% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $150.57 | +6.26% | 2 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $500 | $300.43 | +66.43% | 7 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $44.94 | +0.13% | 2 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $230 | $129.36 | +77.80% | 1 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 → $25 | $28.34 | -11.79% | 11 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $18.45 | - | 1 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 → $60 | $37.04 | +61.99% | 5 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $8.22 | +118.98% | 15 | Dec 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $25.37 | n/a | 2 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40 | $0.30 | n/a | 1 | Sep 29, 2025 |
Bright Minds Biosciences
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $80 → $150
Current: $20.40
Upside: +635.29%
Ovid Therapeutics
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $2.20
Upside: +127.27%
Rapport Therapeutics
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $23.16
Upside: +115.89%
Harmony Biosciences Holdings
Aug 26, 2026
Initiated Coverage: Buy
Price Target: $60
Current: $32.59
Upside: +84.11%
Immunic
Aug 11, 2026
Reiterated: Buy
Price Target: $30 → $25
Current: $6.99
Upside: +257.65%
Stoke Therapeutics
Aug 3, 2026
Reiterated: Buy
Price Target: $40
Current: $26.81
Upside: +49.20%
uniQure
Jul 29, 2026
Upgraded: Buy
Price Target: $65
Current: $19.35
Upside: +235.92%
COMPASS Pathways
Jul 7, 2026
Reiterated: Buy
Price Target: $18
Current: $8.05
Upside: +123.60%
LB Pharmaceuticals
Jul 7, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $38.85
Upside: +15.83%
Seaport Therapeutics
Jul 7, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $18.05
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $33
Current: $17.11
Upside: +92.87%
Apr 6, 2026
Reiterated: Buy
Price Target: $160
Current: $150.57
Upside: +6.26%
Apr 6, 2026
Reiterated: Buy
Price Target: $500
Current: $300.43
Upside: +66.43%
Feb 23, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $44.94
Upside: +0.13%
Feb 23, 2026
Initiated Coverage: Buy
Price Target: $230
Current: $129.36
Upside: +77.80%
Feb 23, 2026
Initiated Coverage: Buy
Price Target: $20 → $25
Current: $28.34
Upside: -11.79%
Feb 23, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $18.45
Upside: -
Feb 23, 2026
Initiated Coverage: Buy
Price Target: $55 → $60
Current: $37.04
Upside: +61.99%
Dec 31, 2025
Initiated Coverage: Buy
Price Target: $18
Current: $8.22
Upside: +118.98%
Oct 20, 2025
Reiterated: Buy
Price Target: $15
Current: $25.37
Upside: n/a
Sep 29, 2025
Initiated Coverage: Buy
Price Target: $40
Current: $0.30
Upside: n/a